Harmony Biosciences Holdings Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Harmony Biosciences Holdings Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Plymouth Meeting
- Headquarters state / province
- Pennsylvania
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- HRMY
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001802665
- EIN
- 82-2279923
Board of directors
-
Antonio J. Gracias · DirectorSince 2023
-
Gary Sender · DirectorSince 2023
-
Geno J. Germano · DirectorSince 2026
-
Jack Nielsen · DirectorSince 2023
-
Jeffrey M. Dayno · Director · PRESIDENT, CEOSince 2023
-
Juan A. Sabater · DirectorSince 2023
-
Linda M. Szyper · DirectorSince 2023
-
Peter Anastasiou · DirectorSince 2023
-
R. Mark Graf · DirectorSince 2023
-
Ron M. Philip · DirectorSince 2025
-
Troy A. Ignelzi · DirectorSince 2026
Chief executives
Jeffrey M. Dayno
· PRESIDENT, CEO
Dates unknown
Director election results
Annual meeting of May 14, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
68.5%
-
70.6%
-
96.7%
Board connections
7 of this board's directors also sit on 13 other boards.
- via Jack Nielsen
- via Jack Nielsen
- via Gary Sender
- via Ron M. Philip
- via Troy A. Ignelzi
- via Geno J. Germano
- via Jack Nielsen
- via R. Mark Graf
- via Geno J. Germano
- via Gary Sender
- via R. Mark Graf
- via Antonio J. Gracias
- via Gary Sender
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $5,951,586
- 13 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 18, 2026 | Budur Kumar Officer (CHIEF MEDICAL OFFICER) | Option exercise | +10,406 | $30.69 | $319,360 |
| Sep 18, 2026 | Budur Kumar Officer (CHIEF MEDICAL OFFICER) | Option exercise | +25,446 | $30.27 | $770,250 |
| Sep 18, 2026 | Budur Kumar Officer (CHIEF MEDICAL OFFICER) | Open-market sale | −35,852 | $43.05 | $1,543,590 |
| Sep 17, 2026 | Budur Kumar Officer (CHIEF MEDICAL OFFICER) | Option exercise | +400 | $30.69 | $12,276 |
| Sep 17, 2026 | Budur Kumar Officer (CHIEF MEDICAL OFFICER) | Option exercise | +400 | $30.27 | $12,108 |
| Sep 17, 2026 | Budur Kumar Officer (CHIEF MEDICAL OFFICER) | Open-market sale | −800 | $43.00 | $34,400 |
| Sep 16, 2026 | Budur Kumar Officer (CHIEF MEDICAL OFFICER) | Option exercise | +900 | $30.69 | $27,621 |
| Sep 16, 2026 | Budur Kumar Officer (CHIEF MEDICAL OFFICER) | Option exercise | +900 | $30.27 | $27,243 |
| Sep 16, 2026 | Budur Kumar Officer (CHIEF MEDICAL OFFICER) | Open-market sale | −1,800 | $43.01 | $77,426 |
| Sep 8, 2026 | Budur Kumar Officer (CHIEF MEDICAL OFFICER) | Open-market sale | −4,500 | $42.25 | $190,114 |
| Sep 8, 2026 | Budur Kumar Officer (CHIEF MEDICAL OFFICER) | Open-market sale | −1,000 | $42.79 | $42,795 |
| Sep 8, 2026 | Budur Kumar Officer (CHIEF MEDICAL OFFICER) | Option exercise | +12,200 | $30.69 | $374,418 |
| Sep 8, 2026 | Budur Kumar Officer (CHIEF MEDICAL OFFICER) | Option exercise | +10,754 | $30.27 | $325,524 |
| Sep 8, 2026 | Budur Kumar Officer (CHIEF MEDICAL OFFICER) | Open-market sale | −22,954 | $43.10 | $989,350 |
| Sep 4, 2026 | Budur Kumar Officer (CHIEF MEDICAL OFFICER) | Open-market sale | −5,500 | $41.98 | $230,911 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.